Clinical trial
A Single Arm Trial of Toripalimab With Neoadjuvant Carboplatin and Paclitaxel for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT04177797 is registered in ClinicalTrials.gov with Sichuan Cancer Hospital and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Arm Trial of Toripalimab With Neoadjuvant Carboplatin and Paclitaxel for Locally Advanced Esophageal Squamous Cell Carcinoma
- Lead sponsor
- Sichuan Cancer Hospital and Research Institute
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 20, 2020
- Completion date
- December 31, 2023
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.